Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance). [electronic resource] by
- Barton, Debra L
- Thanarajasingam, Gita
- Sloan, Jeff A
- Diekmann, Brent
- Fuloria, Jyotsna
- Kottschade, Lisa A
- Lyss, Alan P
- Jaslowski, Anthony J
- Mazurczak, Miroslaw A
- Blair, Scott C
- Terstriep, Shelby
- Loprinzi, Charles L
Producer: 20150225
In:
Cancer vol. 120
Availability: No items available.
|